Physician profile
Naila Abdullah
NPI 1700372273
$1,259.64
in general payments reported to CMS, 2019-2025
12 companies · $58.84 in 2025
The $58.84 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $230 · 2021: $184 · 2022: $59.01 · 2023: $104 · 2024: $257 · 2025: $58.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $237.50 | 2019-2020 | |
| Novo Nordisk INC | $184.09 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $124.78 | 2024 | Lokelma |
| Mallinckrodt Enterprises LLC | $117.18 | 2019 | |
| Vifor Pharma, INC. | $116.34 | 2020 | |
| Csl Behring | $110.71 | 2024 | Kcentra |
| Pfizer INC. | $93.82 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $53.02 | 2023 | Zerbaxa, Dificid, Recarbrio |
| Inari Medical, INC. | $40.75 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $34.63 | 2022-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $21.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naila Abdullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.